nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—ABCB1—peripheral nervous system neoplasm	0.248	1	CbGaD
Clomipramine—GSTP1—Cisplatin—peripheral nervous system neoplasm	0.141	0.293	CbGbCtD
Clomipramine—GSTP1—Etoposide—peripheral nervous system neoplasm	0.139	0.287	CbGbCtD
Clomipramine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0265	0.055	CbGbCtD
Clomipramine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0232	0.0481	CbGbCtD
Clomipramine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0232	0.0481	CbGbCtD
Clomipramine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0212	0.0439	CbGbCtD
Clomipramine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0161	0.0333	CbGbCtD
Clomipramine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0139	0.0288	CbGbCtD
Clomipramine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0129	0.0268	CbGbCtD
Clomipramine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0104	0.0215	CbGbCtD
Clomipramine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00991	0.0205	CbGbCtD
Clomipramine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00924	0.0191	CbGbCtD
Clomipramine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00908	0.0188	CbGbCtD
Clomipramine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00619	0.0128	CbGbCtD
Clomipramine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00594	0.0123	CbGbCtD
Clomipramine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00584	0.0121	CbGbCtD
Clomipramine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00544	0.0113	CbGbCtD
Clomipramine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00416	0.204	CbGeAlD
Clomipramine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00371	0.00768	CbGbCtD
Clomipramine—HTR6—ganglion—peripheral nervous system neoplasm	0.00189	0.0928	CbGeAlD
Clomipramine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00152	0.0746	CbGeAlD
Clomipramine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00142	0.0698	CbGeAlD
Clomipramine—HTR2C—ganglion—peripheral nervous system neoplasm	0.00109	0.0536	CbGeAlD
Clomipramine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00108	0.0532	CbGeAlD
Clomipramine—HTR2A—pons—peripheral nervous system neoplasm	0.00107	0.0525	CbGeAlD
Clomipramine—SLC6A4—ganglion—peripheral nervous system neoplasm	0.00104	0.0508	CbGeAlD
Clomipramine—SLC6A2—nerve—peripheral nervous system neoplasm	0.000923	0.0453	CbGeAlD
Clomipramine—SLC6A2—ganglion—peripheral nervous system neoplasm	0.000912	0.0448	CbGeAlD
Clomipramine—Amitriptyline—NTRK2—peripheral nervous system neoplasm	0.000809	0.263	CrCbGaD
Clomipramine—GSTP1—trigeminal ganglion—peripheral nervous system neoplasm	0.000611	0.03	CbGeAlD
Clomipramine—GSTP1—parotid gland—peripheral nervous system neoplasm	0.000577	0.0283	CbGeAlD
Clomipramine—HTR2A—nerve—peripheral nervous system neoplasm	0.000555	0.0272	CbGeAlD
Clomipramine—HTR2A—ganglion—peripheral nervous system neoplasm	0.000548	0.0269	CbGeAlD
Clomipramine—Amitriptyline—NTRK1—peripheral nervous system neoplasm	0.0005	0.162	CrCbGaD
Clomipramine—HTR2C—brainstem—peripheral nervous system neoplasm	0.000475	0.0233	CbGeAlD
Clomipramine—SLC6A4—brainstem—peripheral nervous system neoplasm	0.00045	0.0221	CbGeAlD
Clomipramine—SLC6A2—brainstem—peripheral nervous system neoplasm	0.000396	0.0195	CbGeAlD
Clomipramine—Triflupromazine—BCHE—peripheral nervous system neoplasm	0.000375	0.122	CrCbGaD
Clomipramine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000317	0.0155	CbGeAlD
Clomipramine—GSTP1—cerebellum—peripheral nervous system neoplasm	0.000267	0.0131	CbGeAlD
Clomipramine—HTR2A—brainstem—peripheral nervous system neoplasm	0.000238	0.0117	CbGeAlD
Clomipramine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000217	0.0107	CbGeAlD
Clomipramine—Chlorpromazine—BCHE—peripheral nervous system neoplasm	0.000181	0.0587	CrCbGaD
Clomipramine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000176	0.00866	CbGeAlD
Clomipramine—Triflupromazine—ABCB1—peripheral nervous system neoplasm	0.000147	0.0477	CrCbGaD
Clomipramine—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000138	0.00678	CbGeAlD
Clomipramine—Clobazam—ABCB1—peripheral nervous system neoplasm	0.000131	0.0424	CrCbGaD
Clomipramine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000117	0.00577	CbGeAlD
Clomipramine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000107	0.00525	CbGeAlD
Clomipramine—Chlorprothixene—ABCB1—peripheral nervous system neoplasm	0.000103	0.0334	CrCbGaD
Clomipramine—Flurazepam—ABCB1—peripheral nervous system neoplasm	9.61e-05	0.0312	CrCbGaD
Clomipramine—Trimipramine—ABCB1—peripheral nervous system neoplasm	9.51e-05	0.0309	CrCbGaD
Clomipramine—Promethazine—ABCB1—peripheral nervous system neoplasm	9.15e-05	0.0297	CrCbGaD
Clomipramine—Doxepin—ABCB1—peripheral nervous system neoplasm	9.06e-05	0.0294	CrCbGaD
Clomipramine—Trifluoperazine—ABCB1—peripheral nervous system neoplasm	9.03e-05	0.0293	CrCbGaD
Clomipramine—Desipramine—ABCB1—peripheral nervous system neoplasm	8.31e-05	0.027	CrCbGaD
Clomipramine—ABCB1—cerebellum—peripheral nervous system neoplasm	7.7e-05	0.00378	CbGeAlD
Clomipramine—Diazepam—ABCB1—peripheral nervous system neoplasm	7.63e-05	0.0248	CrCbGaD
Clomipramine—Chlorpromazine—ABCB1—peripheral nervous system neoplasm	7.09e-05	0.023	CrCbGaD
Clomipramine—Imipramine—ABCB1—peripheral nervous system neoplasm	7.05e-05	0.0229	CrCbGaD
Clomipramine—Amitriptyline—ABCB1—peripheral nervous system neoplasm	7.01e-05	0.0227	CrCbGaD
Clomipramine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	6.45e-05	0.000276	CcSEcCtD
Clomipramine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	6.45e-05	0.000276	CcSEcCtD
Clomipramine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	6.43e-05	0.000275	CcSEcCtD
Clomipramine—Somnolence—Etoposide—peripheral nervous system neoplasm	6.43e-05	0.000275	CcSEcCtD
Clomipramine—Asthenia—Vincristine—peripheral nervous system neoplasm	6.4e-05	0.000274	CcSEcCtD
Clomipramine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	6.39e-05	0.000274	CcSEcCtD
Clomipramine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000272	CcSEcCtD
Clomipramine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	6.35e-05	0.000272	CcSEcCtD
Clomipramine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.000272	CcSEcCtD
Clomipramine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	6.34e-05	0.000271	CcSEcCtD
Clomipramine—Rash—Dactinomycin—peripheral nervous system neoplasm	6.3e-05	0.00027	CcSEcCtD
Clomipramine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	6.29e-05	0.000269	CcSEcCtD
Clomipramine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	6.26e-05	0.000268	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	6.24e-05	0.000267	CcSEcCtD
Clomipramine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	6.24e-05	0.000267	CcSEcCtD
Clomipramine—Fatigue—Etoposide—peripheral nervous system neoplasm	6.23e-05	0.000267	CcSEcCtD
Clomipramine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	6.23e-05	0.000267	CcSEcCtD
Clomipramine—Jaundice—Epirubicin—peripheral nervous system neoplasm	6.19e-05	0.000265	CcSEcCtD
Clomipramine—Pain—Etoposide—peripheral nervous system neoplasm	6.18e-05	0.000265	CcSEcCtD
Clomipramine—Constipation—Etoposide—peripheral nervous system neoplasm	6.18e-05	0.000265	CcSEcCtD
Clomipramine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	6.18e-05	0.000264	CcSEcCtD
Clomipramine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	6.18e-05	0.000264	CcSEcCtD
Clomipramine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	6.17e-05	0.000264	CcSEcCtD
Clomipramine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	6.12e-05	0.000262	CcSEcCtD
Clomipramine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	6.11e-05	0.000261	CcSEcCtD
Clomipramine—Sweating—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000261	CcSEcCtD
Clomipramine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	6.09e-05	0.000261	CcSEcCtD
Clomipramine—Haematuria—Epirubicin—peripheral nervous system neoplasm	6.06e-05	0.000259	CcSEcCtD
Clomipramine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	6.02e-05	0.000258	CcSEcCtD
Clomipramine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	6.01e-05	0.000257	CcSEcCtD
Clomipramine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	6e-05	0.000257	CcSEcCtD
Clomipramine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	5.99e-05	0.000257	CcSEcCtD
Clomipramine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	5.97e-05	0.000255	CcSEcCtD
Clomipramine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.000255	CcSEcCtD
Clomipramine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	5.96e-05	0.000255	CcSEcCtD
Clomipramine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	5.95e-05	0.000255	CcSEcCtD
Clomipramine—Nausea—Dactinomycin—peripheral nervous system neoplasm	5.93e-05	0.000254	CcSEcCtD
Clomipramine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	5.93e-05	0.000254	CcSEcCtD
Clomipramine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	5.91e-05	0.000253	CcSEcCtD
Clomipramine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	5.91e-05	0.000253	CcSEcCtD
Clomipramine—Dizziness—Vincristine—peripheral nervous system neoplasm	5.9e-05	0.000253	CcSEcCtD
Clomipramine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	5.89e-05	0.000252	CcSEcCtD
Clomipramine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	5.88e-05	0.000252	CcSEcCtD
Clomipramine—Rash—Alitretinoin—peripheral nervous system neoplasm	5.84e-05	0.00025	CcSEcCtD
Clomipramine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	5.83e-05	0.00025	CcSEcCtD
Clomipramine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	5.81e-05	0.000249	CcSEcCtD
Clomipramine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.000249	CcSEcCtD
Clomipramine—Headache—Alitretinoin—peripheral nervous system neoplasm	5.8e-05	0.000248	CcSEcCtD
Clomipramine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	5.76e-05	0.000247	CcSEcCtD
Clomipramine—Urticaria—Etoposide—peripheral nervous system neoplasm	5.74e-05	0.000246	CcSEcCtD
Clomipramine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	5.73e-05	0.000245	CcSEcCtD
Clomipramine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	5.72e-05	0.000245	CcSEcCtD
Clomipramine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	5.72e-05	0.000245	CcSEcCtD
Clomipramine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	5.72e-05	0.000245	CcSEcCtD
Clomipramine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000245	CcSEcCtD
Clomipramine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000245	CcSEcCtD
Clomipramine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	5.7e-05	0.000244	CcSEcCtD
Clomipramine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	5.68e-05	0.000243	CcSEcCtD
Clomipramine—Vomiting—Vincristine—peripheral nervous system neoplasm	5.67e-05	0.000243	CcSEcCtD
Clomipramine—Asthenia—Cisplatin—peripheral nervous system neoplasm	5.66e-05	0.000242	CcSEcCtD
Clomipramine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	5.66e-05	0.000242	CcSEcCtD
Clomipramine—Sweating—Doxorubicin—peripheral nervous system neoplasm	5.64e-05	0.000241	CcSEcCtD
Clomipramine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.000241	CcSEcCtD
Clomipramine—Rash—Vincristine—peripheral nervous system neoplasm	5.63e-05	0.000241	CcSEcCtD
Clomipramine—Dermatitis—Vincristine—peripheral nervous system neoplasm	5.62e-05	0.000241	CcSEcCtD
Clomipramine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	5.61e-05	0.00024	CcSEcCtD
Clomipramine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	5.61e-05	0.00024	CcSEcCtD
Clomipramine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	5.59e-05	0.000239	CcSEcCtD
Clomipramine—Headache—Vincristine—peripheral nervous system neoplasm	5.59e-05	0.000239	CcSEcCtD
Clomipramine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	5.56e-05	0.000238	CcSEcCtD
Clomipramine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	5.55e-05	0.000237	CcSEcCtD
Clomipramine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	5.52e-05	0.000236	CcSEcCtD
Clomipramine—Nausea—Alitretinoin—peripheral nervous system neoplasm	5.5e-05	0.000236	CcSEcCtD
Clomipramine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	5.5e-05	0.000235	CcSEcCtD
Clomipramine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	5.49e-05	0.000235	CcSEcCtD
Clomipramine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	5.4e-05	0.000231	CcSEcCtD
Clomipramine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.00023	CcSEcCtD
Clomipramine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	5.33e-05	0.000228	CcSEcCtD
Clomipramine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	5.33e-05	0.000228	CcSEcCtD
Clomipramine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	5.32e-05	0.000228	CcSEcCtD
Clomipramine—Nausea—Vincristine—peripheral nervous system neoplasm	5.3e-05	0.000227	CcSEcCtD
Clomipramine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	5.29e-05	0.000227	CcSEcCtD
Clomipramine—Flushing—Epirubicin—peripheral nervous system neoplasm	5.29e-05	0.000227	CcSEcCtD
Clomipramine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	5.29e-05	0.000227	CcSEcCtD
Clomipramine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000226	CcSEcCtD
Clomipramine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.000225	CcSEcCtD
Clomipramine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	5.24e-05	0.000224	CcSEcCtD
Clomipramine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000223	CcSEcCtD
Clomipramine—Asthenia—Etoposide—peripheral nervous system neoplasm	5.19e-05	0.000222	CcSEcCtD
Clomipramine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	5.19e-05	0.000222	CcSEcCtD
Clomipramine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	5.18e-05	0.000222	CcSEcCtD
Clomipramine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	5.17e-05	0.000222	CcSEcCtD
Clomipramine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	5.15e-05	0.000221	CcSEcCtD
Clomipramine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	5.14e-05	0.00022	CcSEcCtD
Clomipramine—Chills—Epirubicin—peripheral nervous system neoplasm	5.12e-05	0.000219	CcSEcCtD
Clomipramine—Pruritus—Etoposide—peripheral nervous system neoplasm	5.12e-05	0.000219	CcSEcCtD
Clomipramine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	5.1e-05	0.000218	CcSEcCtD
Clomipramine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	5.09e-05	0.000218	CcSEcCtD
Clomipramine—Alopecia—Epirubicin—peripheral nervous system neoplasm	5.04e-05	0.000216	CcSEcCtD
Clomipramine—Vomiting—Cisplatin—peripheral nervous system neoplasm	5.02e-05	0.000215	CcSEcCtD
Clomipramine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	5e-05	0.000214	CcSEcCtD
Clomipramine—Rash—Cisplatin—peripheral nervous system neoplasm	4.98e-05	0.000213	CcSEcCtD
Clomipramine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	4.97e-05	0.000213	CcSEcCtD
Clomipramine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	4.97e-05	0.000213	CcSEcCtD
Clomipramine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	4.95e-05	0.000212	CcSEcCtD
Clomipramine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.000211	CcSEcCtD
Clomipramine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	4.92e-05	0.000211	CcSEcCtD
Clomipramine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	4.9e-05	0.00021	CcSEcCtD
Clomipramine—Flushing—Doxorubicin—peripheral nervous system neoplasm	4.9e-05	0.00021	CcSEcCtD
Clomipramine—Flatulence—Epirubicin—peripheral nervous system neoplasm	4.89e-05	0.00021	CcSEcCtD
Clomipramine—Tension—Epirubicin—peripheral nervous system neoplasm	4.87e-05	0.000209	CcSEcCtD
Clomipramine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	4.86e-05	0.000208	CcSEcCtD
Clomipramine—Nervousness—Epirubicin—peripheral nervous system neoplasm	4.82e-05	0.000207	CcSEcCtD
Clomipramine—Back pain—Epirubicin—peripheral nervous system neoplasm	4.8e-05	0.000206	CcSEcCtD
Clomipramine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.000205	CcSEcCtD
Clomipramine—Dizziness—Etoposide—peripheral nervous system neoplasm	4.78e-05	0.000205	CcSEcCtD
Clomipramine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	4.77e-05	0.000204	CcSEcCtD
Clomipramine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	4.77e-05	0.000204	CcSEcCtD
Clomipramine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.76e-05	0.000204	CcSEcCtD
Clomipramine—Chills—Doxorubicin—peripheral nervous system neoplasm	4.74e-05	0.000203	CcSEcCtD
Clomipramine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	4.72e-05	0.000202	CcSEcCtD
Clomipramine—Nausea—Cisplatin—peripheral nervous system neoplasm	4.69e-05	0.000201	CcSEcCtD
Clomipramine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	4.68e-05	0.0002	CcSEcCtD
Clomipramine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	4.66e-05	0.0002	CcSEcCtD
Clomipramine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	4.62e-05	0.000198	CcSEcCtD
Clomipramine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	4.61e-05	0.000197	CcSEcCtD
Clomipramine—Vomiting—Etoposide—peripheral nervous system neoplasm	4.6e-05	0.000197	CcSEcCtD
Clomipramine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000197	CcSEcCtD
Clomipramine—Anaemia—Epirubicin—peripheral nervous system neoplasm	4.59e-05	0.000197	CcSEcCtD
Clomipramine—Agitation—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000195	CcSEcCtD
Clomipramine—Rash—Etoposide—peripheral nervous system neoplasm	4.56e-05	0.000195	CcSEcCtD
Clomipramine—Dermatitis—Etoposide—peripheral nervous system neoplasm	4.55e-05	0.000195	CcSEcCtD
Clomipramine—Headache—Etoposide—peripheral nervous system neoplasm	4.53e-05	0.000194	CcSEcCtD
Clomipramine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	4.53e-05	0.000194	CcSEcCtD
Clomipramine—Tension—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.000193	CcSEcCtD
Clomipramine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	4.5e-05	0.000193	CcSEcCtD
Clomipramine—Malaise—Epirubicin—peripheral nervous system neoplasm	4.48e-05	0.000192	CcSEcCtD
Clomipramine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	4.46e-05	0.000191	CcSEcCtD
Clomipramine—Vertigo—Epirubicin—peripheral nervous system neoplasm	4.46e-05	0.000191	CcSEcCtD
Clomipramine—Syncope—Epirubicin—peripheral nervous system neoplasm	4.45e-05	0.000191	CcSEcCtD
Clomipramine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	4.45e-05	0.00019	CcSEcCtD
Clomipramine—Back pain—Doxorubicin—peripheral nervous system neoplasm	4.44e-05	0.00019	CcSEcCtD
Clomipramine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	0.000189	CcSEcCtD
Clomipramine—Palpitations—Epirubicin—peripheral nervous system neoplasm	4.39e-05	0.000188	CcSEcCtD
Clomipramine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	4.36e-05	0.000187	CcSEcCtD
Clomipramine—Cough—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000186	CcSEcCtD
Clomipramine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	4.33e-05	0.000185	CcSEcCtD
Clomipramine—Convulsion—Epirubicin—peripheral nervous system neoplasm	4.3e-05	0.000184	CcSEcCtD
Clomipramine—Nausea—Etoposide—peripheral nervous system neoplasm	4.29e-05	0.000184	CcSEcCtD
Clomipramine—Hypertension—Epirubicin—peripheral nervous system neoplasm	4.29e-05	0.000184	CcSEcCtD
Clomipramine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	4.26e-05	0.000183	CcSEcCtD
Clomipramine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	4.25e-05	0.000182	CcSEcCtD
Clomipramine—Myalgia—Epirubicin—peripheral nervous system neoplasm	4.23e-05	0.000181	CcSEcCtD
Clomipramine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	4.23e-05	0.000181	CcSEcCtD
Clomipramine—Chest pain—Epirubicin—peripheral nervous system neoplasm	4.23e-05	0.000181	CcSEcCtD
Clomipramine—Agitation—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000181	CcSEcCtD
Clomipramine—Anxiety—Epirubicin—peripheral nervous system neoplasm	4.21e-05	0.00018	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.00018	CcSEcCtD
Clomipramine—Discomfort—Epirubicin—peripheral nervous system neoplasm	4.18e-05	0.000179	CcSEcCtD
Clomipramine—Malaise—Doxorubicin—peripheral nervous system neoplasm	4.14e-05	0.000177	CcSEcCtD
Clomipramine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	4.13e-05	0.000177	CcSEcCtD
Clomipramine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	4.13e-05	0.000177	CcSEcCtD
Clomipramine—Syncope—Doxorubicin—peripheral nervous system neoplasm	4.12e-05	0.000176	CcSEcCtD
Clomipramine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	4.11e-05	0.000176	CcSEcCtD
Clomipramine—Confusional state—Epirubicin—peripheral nervous system neoplasm	4.09e-05	0.000175	CcSEcCtD
Clomipramine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	4.06e-05	0.000174	CcSEcCtD
Clomipramine—Oedema—Epirubicin—peripheral nervous system neoplasm	4.05e-05	0.000174	CcSEcCtD
Clomipramine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	4.05e-05	0.000174	CcSEcCtD
Clomipramine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	4.04e-05	0.000173	CcSEcCtD
Clomipramine—Cough—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000172	CcSEcCtD
Clomipramine—Shock—Epirubicin—peripheral nervous system neoplasm	3.99e-05	0.000171	CcSEcCtD
Clomipramine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	3.98e-05	0.00017	CcSEcCtD
Clomipramine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	3.97e-05	0.00017	CcSEcCtD
Clomipramine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.97e-05	0.00017	CcSEcCtD
Clomipramine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	3.97e-05	0.00017	CcSEcCtD
Clomipramine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	3.96e-05	0.000169	CcSEcCtD
Clomipramine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	3.94e-05	0.000169	CcSEcCtD
Clomipramine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	3.92e-05	0.000168	CcSEcCtD
Clomipramine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	3.91e-05	0.000168	CcSEcCtD
Clomipramine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	3.91e-05	0.000168	CcSEcCtD
Clomipramine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	3.91e-05	0.000168	CcSEcCtD
Clomipramine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	3.9e-05	0.000167	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.000166	CcSEcCtD
Clomipramine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000166	CcSEcCtD
Clomipramine—Anorexia—Epirubicin—peripheral nervous system neoplasm	3.86e-05	0.000165	CcSEcCtD
Clomipramine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.000164	CcSEcCtD
Clomipramine—Hypotension—Epirubicin—peripheral nervous system neoplasm	3.79e-05	0.000162	CcSEcCtD
Clomipramine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	3.78e-05	0.000162	CcSEcCtD
Clomipramine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	3.75e-05	0.000161	CcSEcCtD
Clomipramine—Oedema—Doxorubicin—peripheral nervous system neoplasm	3.75e-05	0.000161	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	3.69e-05	0.000158	CcSEcCtD
Clomipramine—Shock—Doxorubicin—peripheral nervous system neoplasm	3.69e-05	0.000158	CcSEcCtD
Clomipramine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	3.68e-05	0.000157	CcSEcCtD
Clomipramine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	3.67e-05	0.000157	CcSEcCtD
Clomipramine—Insomnia—Epirubicin—peripheral nervous system neoplasm	3.67e-05	0.000157	CcSEcCtD
Clomipramine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	3.66e-05	0.000157	CcSEcCtD
Clomipramine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	3.64e-05	0.000156	CcSEcCtD
Clomipramine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	3.64e-05	0.000156	CcSEcCtD
Clomipramine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	3.63e-05	0.000155	CcSEcCtD
Clomipramine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	3.61e-05	0.000155	CcSEcCtD
Clomipramine—Somnolence—Epirubicin—peripheral nervous system neoplasm	3.6e-05	0.000154	CcSEcCtD
Clomipramine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	3.57e-05	0.000153	CcSEcCtD
Clomipramine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	3.57e-05	0.000153	CcSEcCtD
Clomipramine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	3.52e-05	0.000151	CcSEcCtD
Clomipramine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	3.5e-05	0.00015	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	3.5e-05	0.00015	CcSEcCtD
Clomipramine—Fatigue—Epirubicin—peripheral nervous system neoplasm	3.49e-05	0.00015	CcSEcCtD
Clomipramine—Pain—Epirubicin—peripheral nervous system neoplasm	3.47e-05	0.000148	CcSEcCtD
Clomipramine—Constipation—Epirubicin—peripheral nervous system neoplasm	3.47e-05	0.000148	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.000146	CcSEcCtD
Clomipramine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	3.39e-05	0.000145	CcSEcCtD
Clomipramine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	3.37e-05	0.000144	CcSEcCtD
Clomipramine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.000143	CcSEcCtD
Clomipramine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	3.34e-05	0.000143	CcSEcCtD
Clomipramine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.000143	CcSEcCtD
Clomipramine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.000142	CcSEcCtD
Clomipramine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	3.3e-05	0.000141	CcSEcCtD
Clomipramine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.26e-05	0.00014	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.24e-05	0.000139	CcSEcCtD
Clomipramine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.23e-05	0.000138	CcSEcCtD
Clomipramine—Urticaria—Epirubicin—peripheral nervous system neoplasm	3.22e-05	0.000138	CcSEcCtD
Clomipramine—Pain—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000137	CcSEcCtD
Clomipramine—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000137	CcSEcCtD
Clomipramine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.2e-05	0.000137	CcSEcCtD
Clomipramine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.2e-05	0.000137	CcSEcCtD
Clomipramine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.09e-05	0.000132	CcSEcCtD
Clomipramine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.000131	CcSEcCtD
Clomipramine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.99e-05	0.000128	CcSEcCtD
Clomipramine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.98e-05	0.000128	CcSEcCtD
Clomipramine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.96e-05	0.000127	CcSEcCtD
Clomipramine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.96e-05	0.000127	CcSEcCtD
Clomipramine—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.91e-05	0.000125	CcSEcCtD
Clomipramine—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.87e-05	0.000123	CcSEcCtD
Clomipramine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.77e-05	0.000119	CcSEcCtD
Clomipramine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.76e-05	0.000118	CcSEcCtD
Clomipramine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.69e-05	0.000115	CcSEcCtD
Clomipramine—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.68e-05	0.000115	CcSEcCtD
Clomipramine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.65e-05	0.000114	CcSEcCtD
Clomipramine—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.58e-05	0.00011	CcSEcCtD
Clomipramine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.57e-05	0.00011	CcSEcCtD
Clomipramine—Rash—Epirubicin—peripheral nervous system neoplasm	2.56e-05	0.000109	CcSEcCtD
Clomipramine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.55e-05	0.000109	CcSEcCtD
Clomipramine—Headache—Epirubicin—peripheral nervous system neoplasm	2.54e-05	0.000109	CcSEcCtD
Clomipramine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.48e-05	0.000106	CcSEcCtD
Clomipramine—Nausea—Epirubicin—peripheral nervous system neoplasm	2.41e-05	0.000103	CcSEcCtD
Clomipramine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.38e-05	0.000102	CcSEcCtD
Clomipramine—Rash—Doxorubicin—peripheral nervous system neoplasm	2.36e-05	0.000101	CcSEcCtD
Clomipramine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.36e-05	0.000101	CcSEcCtD
Clomipramine—Headache—Doxorubicin—peripheral nervous system neoplasm	2.35e-05	0.000101	CcSEcCtD
Clomipramine—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.23e-05	9.54e-05	CcSEcCtD
Clomipramine—ADRA2A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.33e-05	0.00113	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.32e-05	0.00112	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.3e-05	0.0011	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.29e-05	0.0011	CbGpPWpGaD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	1.25e-05	0.00106	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.25e-05	0.00106	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.23e-05	0.00105	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GNS—peripheral nervous system neoplasm	1.23e-05	0.00104	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.23e-05	0.00104	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.22e-05	0.00103	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.22e-05	0.00103	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.21e-05	0.00102	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.2e-05	0.00102	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—GNAS—peripheral nervous system neoplasm	1.19e-05	0.00101	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.18e-05	0.001	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—NME1—peripheral nervous system neoplasm	1.18e-05	0.000998	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.17e-05	0.000996	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.17e-05	0.000995	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	1.16e-05	0.000982	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—HGF—peripheral nervous system neoplasm	1.13e-05	0.000961	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—COX2—peripheral nervous system neoplasm	1.13e-05	0.000961	CbGpPWpGaD
Clomipramine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.13e-05	0.00096	CbGpPWpGaD
Clomipramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.13e-05	0.000959	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.13e-05	0.000957	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.13e-05	0.000955	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.11e-05	0.000944	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.11e-05	0.000938	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.09e-05	0.000923	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	1.08e-05	0.000919	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.08e-05	0.000917	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	1.07e-05	0.00091	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.07e-05	0.000908	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.07e-05	0.000908	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.06e-05	0.000902	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.03e-05	0.000876	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.03e-05	0.00087	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.01e-05	0.000857	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1e-05	0.000848	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	9.89e-06	0.000838	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	9.86e-06	0.000835	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	9.86e-06	0.000835	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VIP—peripheral nervous system neoplasm	9.85e-06	0.000835	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	9.85e-06	0.000834	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GNS—peripheral nervous system neoplasm	9.69e-06	0.000821	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	9.52e-06	0.000807	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	9.46e-06	0.000801	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	9.39e-06	0.000796	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.38e-06	0.000795	CbGpPWpGaD
Clomipramine—ALB—Metabolism—NME1—peripheral nervous system neoplasm	9.29e-06	0.000788	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	9.27e-06	0.000786	CbGpPWpGaD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	9.13e-06	0.000774	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	9.09e-06	0.000771	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.04e-06	0.000766	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	8.95e-06	0.000758	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	8.95e-06	0.000758	CbGpPWpGaD
Clomipramine—ALB—Metabolism—COX2—peripheral nervous system neoplasm	8.95e-06	0.000758	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.86e-06	0.00075	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	8.7e-06	0.000737	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	8.65e-06	0.000733	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	8.6e-06	0.000729	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	8.59e-06	0.000728	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	8.56e-06	0.000725	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	8.49e-06	0.00072	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.46e-06	0.000717	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	8.34e-06	0.000707	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—PTPN11—peripheral nervous system neoplasm	8.27e-06	0.000701	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	8.27e-06	0.000701	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.16e-06	0.000691	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	8.14e-06	0.00069	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.13e-06	0.000689	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	8.03e-06	0.000681	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	8e-06	0.000678	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	7.98e-06	0.000676	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.93e-06	0.000672	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	7.93e-06	0.000672	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.9e-06	0.000669	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	7.84e-06	0.000664	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.81e-06	0.000662	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.79e-06	0.00066	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.78e-06	0.00066	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	7.67e-06	0.00065	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.56e-06	0.000641	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.52e-06	0.000637	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	7.51e-06	0.000636	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.45e-06	0.000631	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ENO2—peripheral nervous system neoplasm	7.44e-06	0.000631	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	7.39e-06	0.000626	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.24e-06	0.000614	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.24e-06	0.000613	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.18e-06	0.000609	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.13e-06	0.000604	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	6.98e-06	0.000592	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.94e-06	0.000588	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.9e-06	0.000585	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.83e-06	0.000579	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.83e-06	0.000579	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	6.78e-06	0.000575	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	6.53e-06	0.000553	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	6.5e-06	0.000551	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.4e-06	0.000542	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.33e-06	0.000537	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	6.29e-06	0.000533	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.28e-06	0.000533	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	6.26e-06	0.00053	CbGpPWpGaD
Clomipramine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	6.23e-06	0.000528	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6.01e-06	0.000509	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	6e-06	0.000508	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.93e-06	0.000503	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	5.91e-06	0.000501	CbGpPWpGaD
Clomipramine—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	5.87e-06	0.000498	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.84e-06	0.000495	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	5.74e-06	0.000486	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.57e-06	0.000472	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.4e-06	0.000457	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	5.27e-06	0.000447	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	5.23e-06	0.000443	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.22e-06	0.000442	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	5.15e-06	0.000436	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.11e-06	0.000433	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.07e-06	0.00043	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	5.02e-06	0.000425	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	4.97e-06	0.000422	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.97e-06	0.000421	CbGpPWpGaD
Clomipramine—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	4.96e-06	0.000421	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	4.92e-06	0.000417	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.91e-06	0.000416	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	4.85e-06	0.000411	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.84e-06	0.00041	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.83e-06	0.00041	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	4.83e-06	0.000409	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	4.83e-06	0.000409	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.82e-06	0.000408	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.75e-06	0.000402	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	4.74e-06	0.000401	CbGpPWpGaD
Clomipramine—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.73e-06	0.000401	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.68e-06	0.000397	CbGpPWpGaD
Clomipramine—ALB—Metabolism—TH—peripheral nervous system neoplasm	4.67e-06	0.000395	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.61e-06	0.000391	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.55e-06	0.000386	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.51e-06	0.000382	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.48e-06	0.00038	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	4.45e-06	0.000378	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.44e-06	0.000376	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.4e-06	0.000373	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.4e-06	0.000373	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	4.35e-06	0.000368	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.25e-06	0.00036	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	4.19e-06	0.000355	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.15e-06	0.000352	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.13e-06	0.00035	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	4.11e-06	0.000348	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	4.1e-06	0.000347	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	4.09e-06	0.000346	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.04e-06	0.000342	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	3.93e-06	0.000333	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—AKT1—peripheral nervous system neoplasm	3.91e-06	0.000331	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.91e-06	0.000331	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	3.85e-06	0.000326	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.81e-06	0.000323	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	3.81e-06	0.000323	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	3.8e-06	0.000322	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.78e-06	0.00032	CbGpPWpGaD
Clomipramine—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	3.74e-06	0.000317	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	3.64e-06	0.000308	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.61e-06	0.000306	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.59e-06	0.000304	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.55e-06	0.000301	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.52e-06	0.000298	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.49e-06	0.000296	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.48e-06	0.000295	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	3.47e-06	0.000294	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.46e-06	0.000293	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	3.42e-06	0.00029	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	3.36e-06	0.000284	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	3.34e-06	0.000283	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.31e-06	0.000281	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.28e-06	0.000278	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	3.26e-06	0.000277	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	3.21e-06	0.000272	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.19e-06	0.00027	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	3.17e-06	0.000269	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.17e-06	0.000269	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.16e-06	0.000267	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	3.14e-06	0.000267	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.14e-06	0.000266	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	3.09e-06	0.000262	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.08e-06	0.000261	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	3e-06	0.000254	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.9e-06	0.000246	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.89e-06	0.000245	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.89e-06	0.000245	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	2.87e-06	0.000243	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.85e-06	0.000242	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.81e-06	0.000238	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.8e-06	0.000238	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.76e-06	0.000234	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.7e-06	0.000229	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.68e-06	0.000227	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	2.66e-06	0.000226	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.65e-06	0.000224	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.64e-06	0.000224	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.61e-06	0.000222	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.57e-06	0.000218	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.56e-06	0.000217	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.55e-06	0.000216	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	2.54e-06	0.000215	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	2.52e-06	0.000213	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.46e-06	0.000209	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.44e-06	0.000207	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.44e-06	0.000206	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.33e-06	0.000198	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.3e-06	0.000195	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.23e-06	0.000189	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.22e-06	0.000188	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.22e-06	0.000188	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.21e-06	0.000187	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.13e-06	0.000181	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.12e-06	0.00018	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.09e-06	0.000177	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.06e-06	0.000174	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.03e-06	0.000172	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.03e-06	0.000172	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.02e-06	0.000172	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.02e-06	0.000171	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.01e-06	0.00017	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.99e-06	0.000168	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.94e-06	0.000164	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.87e-06	0.000159	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.85e-06	0.000157	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.84e-06	0.000156	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.73e-06	0.000146	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.71e-06	0.000145	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.69e-06	0.000143	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.63e-06	0.000138	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.57e-06	0.000133	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.56e-06	0.000132	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.42e-06	0.00012	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.38e-06	0.000117	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.36e-06	0.000115	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	1.3e-06	0.00011	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.29e-06	0.000109	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.23e-06	0.000105	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.2e-06	0.000101	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.09e-06	9.23e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.03e-06	8.71e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	9.23e-07	7.82e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	9.01e-07	7.63e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	8.49e-07	7.19e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	7.19e-07	6.09e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	5.55e-07	4.7e-05	CbGpPWpGaD
